|
gptkbp:instanceOf
|
gptkb:cancer
Neuroendocrine Tumor
|
|
gptkbp:alsoKnownAs
|
gptkb:Oat_Cell_Carcinoma
|
|
gptkbp:associatedWith
|
Smoking
|
|
gptkbp:canMetastasizeTo
|
gptkb:bone
gptkb:Brain
Liver
Adrenal Glands
|
|
gptkbp:cause
|
Paraneoplastic Syndromes
|
|
gptkbp:characterizedBy
|
Early Metastasis
Rapid Growth
|
|
gptkbp:commonIn
|
Males
Older Adults
|
|
gptkbp:diagnosedBy
|
Biopsy
Immunohistochemistry
|
|
gptkbp:differentialDiagnosis
|
Lymphoma
Carcinoid Tumor
Non-Small Cell Lung Carcinoma
|
|
gptkbp:firstDescribed
|
1926
|
|
gptkbp:hasGeneticAlteration
|
RB1 Mutation
TP53 Mutation
|
|
gptkbp:histology
|
gptkb:Small_Round_Blue_Cells
Necrosis
High Mitotic Rate
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Small Cell Carcinoma
|
|
gptkbp:ICD-10_code
|
C34.1
|
|
gptkbp:incidence
|
15% of Lung Cancers
|
|
gptkbp:location
|
Lung
|
|
gptkbp:marking
|
gptkb:CD56
gptkb:Chromogranin_A
gptkb:Neuron-Specific_Enolase
gptkb:Synaptophysin
|
|
gptkbp:notTreatedWith
|
Surgery (in most cases)
|
|
gptkbp:occurredIn
|
Bladder
Cervix
Prostate
Gastrointestinal Tract
|
|
gptkbp:paraneoplasticSyndrome
|
gptkb:Cushing_Syndrome
gptkb:Lambert-Eaton_Myasthenic_Syndrome
gptkb:SIADH
|
|
gptkbp:prognosis
|
Poor
|
|
gptkbp:stagedBy
|
Extensive Stage
Limited Stage
|
|
gptkbp:subspecies
|
gptkb:Small_Cell_Lung_Carcinoma
Extrapulmonary Small Cell Carcinoma
|
|
gptkbp:treatment
|
Radiation Therapy
immunotherapy
Chemotherapy
|
|
gptkbp:bfsParent
|
gptkb:Oat_Cell_Carcinoma
|
|
gptkbp:bfsLayer
|
6
|